// November 13, 2020
Breeding a superbug: how poor-quality medicines fuel AMR
Another public health crisis looms in the wake of the COVID-19 pandemic.
Another public health crisis looms in the wake of the COVID-19 pandemic.
With significant innovations in pharmaceuticals, including biologic drugs
The quality of medicine and how it’s delivered to patients is fundamental to treating illness and
By Patricia C. Kienle, RPh, MPA, FASHP